DPA-714, a new translocator protein–specific ligand: Synthesis, radiofluorination, and pharmacologic characterization

…, J Vercoullie, DJ Henderson, L Garreau… - Journal of Nuclear …, 2008 - Soc Nuclear Med
The translocator protein (18 kDa) (TSPO), formerly known as the peripheral benzodiazepine
receptor, is dramatically upregulated under pathologic conditions. Activated microglia are …

Behavior and serotonergic disorders in rats exposed prenatally to valproate: a model for autism

…, P Vourc'h, AM Le Guisquet, L Garreau… - Neuroscience …, 2010 - Elsevier
In order to explore whether some aspects of the autistic phenotype could be related to impairment
of the serotonergic system, we chose an animal model which mimics a potential cause …

Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease

G Bouchez, L Sensebé, P Vourc'h, L Garreau… - Neurochemistry …, 2008 - Elsevier
Cellular therapy with adult stem cells appears as an opportunity for treatment of Parkinson's
disease. To validate this approach, we studied the effects of transplantation of rat adult bone-…

Synthesis and Ligand Binding of Nortropane Derivatives:  N-Substituted 2β-Carbomethoxy-3β-(4'-iodophenyl)nortropane and N-(3-Iodoprop-(2E)-enyl)-2β …

P Emond, L Garreau, S Chalon, M Boazi… - Journal of medicinal …, 1997 - ACS Publications
Two novel series of iodinated N-substituted analogs of 2β-carbomethoxy-3β-(4‘-iodophenyl)tropane
(β-CIT) and N-(3-iodoprop-(2E)-enyl)-2β-carbomethoxy-3β-(3‘,4‘-disubstituted …

Evaluation of CLINDE as potent translocator protein (18 kDa) SPECT radiotracer reflecting the degree of neuroinflammation in a rat model of microglial activation

N Arlicot, A Katsifis, L Garreau, F Mattner… - European journal of …, 2008 - Springer
Background The translocator protein (TSPO; 18 kDa), the new name of the peripheral-type
benzodiazepine receptor, is localised in mitochondria of glial cells and expressed in very low …

Amyloid load and translocator protein 18 kDa in APPswePS1-dE9 mice: a longitudinal study

…, D Guilloteau, M Kassiou, A Doméné, L Garreau… - Neurobiology of …, 2015 - Elsevier
We studied concomitantly the level of neuroinflammation and β-amyloid (Aβ) load in the
APPswePS1dE9 transgenic mouse model of Alzheimer's disease using positron emission …

Exploration of the dopamine transporter: in vitro and in vivo characterization of a high-affinity and high-specificity iodinated tropane derivative (E)-N-(3-iodoprop-2-enyl …

D Guilloteau, P Emond, JL Baulieu, L Garreau… - Nuclear medicine and …, 1998 - Elsevier
For the diagnosis and follow-up of neurodegenerative diseases, many cocaine derivatives
have been proposed as radioligands to explore the dopamine transporter. As none of them …

Pharmacological Characterization ofN, N-Dimethyl-2-(2-amino-4-methylphenyl thio) benzylamine as a Ligand of the Serotonin Transporter with High Affinity and …

S Chalon, J Tarkiainen, L Garreau, H Hall… - … of Pharmacology and …, 2003 - ASPET
Serotonin transporter has a key-role in regulation of serotoninergic function, and is involved
in numerous neurodegenerative and psychiatric disorders. To obtain an efficient radioactive …

Pharmacological characterization of (E)-N-(4-fluorobut-2-enyl)-2β-carbomethoxy-3β-(4′-tolyl) nortropane (LBT-999) as a highly promising fluorinated ligand for the …

S Chalon, H Hall, W Saba, L Garreau, F Dollé… - … of Pharmacology and …, 2006 - ASPET
In the aim to develop an efficient fluorinated probe for positron emission tomography (PET)
exploration of the dopamine transporter (DAT), we studied several in vitro and in vivo …

Pharmacological characterization of (E)-N-(3-iodoprop-2-enyl)-2β-carbomethoxy-3β-(4′-methylphenyl) nortropane as a selective and potent inhibitor of the neuronal …

S Chalon, L Garreau, P Emond, L Zimmer… - … of Pharmacology and …, 1999 - ASPET
The pharmacological properties of the iodinated derivative of cocaine (E)-N-(3-iodoprop-2-enyl)-2β-carbomethoxy-3β-(4′-methylphenyl)nortropane
(PE2I) were evaluated in vitro in …